Picotamide
Clinical data | |
---|---|
AHFS/Drugs.com | International Drug Names |
ATC code | |
Identifiers | |
| |
JSmol) | |
| |
| |
(verify) |
Picotamide is a
thromboxane receptor inhibitor, the latter by modifying cellular responses to activation of the thromboxane receptor.[1] Picotamide is licensed in Italy for the treatment of clinical arterial thrombosis and peripheral artery disease.[2]
References
Further reading
- Celestini A, Violi F (2007). "A review of picotamide in the reduction of cardiovascular events in diabetic patients". Vascular Health and Risk Management. 3 (1): 93–8. PMID 17583179.